Active efflux mechanisms prevent intracellular accumulation of therapeutic agents. Overcoming this limitation restores the efficacy of existing antimicrobial compounds.

Insufficient expression levels and low enzymatic activity in extreme industrial environments. Increasing yield and stability enables viable large-scale biochemical production.